Tinzaparin vs placebo
Adverse events associated with the use of anticoagulants (e.g. bleeding) · people with sickle cell disease
Tinzaparin showed no clear difference in adverse events associated with the use of anticoagulants (e.g.… compared with placebo (low certainty).
1 finding from 1 review
- Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease 2015 · Cochrane Headline outcomes onlyRR 4.96 [0.24, 102.31]1 study · 253 participantsLow